Evidence map›Paper›PMID 32034094›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2020

Unfolding of monomeric lipoprotein lipase by ANGPTL4: Insight into the regulation of plasma triglyceride metabolism.

Kristian K Kristensen, Katrine Zinck Leth-Espensen, Haydyn D T Mertens, Gabriel Birrane, Muthuraman Meiyappan, Gunilla Olivecrona, Thomas J D Jørgensen, Stephen G Young, Michael Ploug

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
9.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 74 citations in OpenAlex.

  1. GPIHBP1 on oligodendrocytes binds lipoprotein lipase within the human brain.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. ANGPTL3/8 is an atypical unfoldase that regulates intravascular lipolysis by catalyzing unfolding of lipoprotein lipase.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. A unified model for regulating lipoprotein lipase activity.Trends in endocrinology and metabolism: TEM · 2024
    Review
  11. Carboxyl-terminal sequences in APOA5 are important for suppressing ANGPTL3/8 activity.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Inverse effects of APOC2 and ANGPTL4 on the conformational dynamics of lid-anchoring structures in lipoprotein lipase.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  17. Angiopoietin-like 3: An important protein in regulating lipoprotein levels.Best practice & research. Clinical endocrinology & metabolism · 2023
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 7 institutions in 4 countries.

Kristian K KristensenFinsen Laboratory, Rigshospitalet, DK-2200 Copenhagen N, Denmark.
Katrine Zinck Leth-EspensenFinsen Laboratory, Rigshospitalet, DK-2200 Copenhagen N, Denmark.
Haydyn D T MertensBIOSAXS Group, European Molecular Biology Laboratory Hamburg, D-22607 Hamburg, Germany.ORCID 0000-0002-5664-744X
Gabriel BirraneDivision of Experimental Medicine, Beth Israel Deaconess Medical Center, Boston, MA 02215.ORCID 0000-0002-1759-5499
Muthuraman MeiyappanDiscovery Therapeutics, Takeda Pharmaceutical Company Ltd., Cambridge, MA 02142.
Gunilla OlivecronaDepartment of Medical Biosciences, Umeå University, 901 87 Umeå, Sweden.
Thomas J D JørgensenDepartment of Biochemistry and Molecular Biology, University of Southern Denmark, DK-5320 Odense M, Denmark.
Stephen G YoungDepartment of Medicine, University of California, Los Angeles, CA 90095; sgyoung@mednet.ucla.edu m-ploug@finsenlab.dk.
Michael PlougFinsen Laboratory, Rigshospitalet, DK-2200 Copenhagen N, Denmark; sgyoung@mednet.ucla.edu m-ploug@finsenlab.dk.ORCID 0000-0003-2215-4265
University of Copenhagen · DKBeth Israel Deaconess Medical Center · USEuropean Molecular Biology Laboratory · DETakeda (United States) · USUmeå University · SEUniversity of California, Los Angeles · USUniversity of Southern Denmark · DK

Funding

The Lipin Protein Family and Triglyceride Metabolism P01HL090553 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI YOUNG, STEPHEN G. · 2008 to 2018
$23.3M
Understanding the Influence of Lipid Homeostasis on T cell FunctionP01HL146358 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI YOUNG, STEPHEN G. · 2019 to 2023
$11.7M
Refining Physiologic Mechanisms for Intravascular Triglyceride MetabolismR01HL087228 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI BEIGNEUX, ANNE, FONG, LOREN GI · 2007 to 2024
$7.8M
Investigating Mechanisms for Lipid Transport in Health and DiseaseR35HL139725 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI YOUNG, STEPHEN G. · 2018 to 2024
$6.1M
Defining mechanisms for lipid transport across capillary endothelial cellsR01HL125335 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI YOUNG, STEPHEN G. · 2015 to 2017
$1.2M
NHLBI NIH HHS P01 HL090553NHLBI NIH HHS P01 HL146358NHLBI NIH HHS R01 HL087228NHLBI NIH HHS R01 HL125335NHLBI NIH HHS R35 HL139725
6 · The paper itself

Abstract

The binding of lipoprotein lipase (LPL) to GPIHBP1 focuses the intravascular hydrolysis of triglyceride-rich lipoproteins on the surface of capillary endothelial cells. This process provides essential lipid nutrients for vital tissues (e.g., heart, skeletal muscle, and adipose tissue). Deficiencies in either LPL or GPIHBP1 impair triglyceride hydrolysis, resulting in severe hypertriglyceridemia. The activity of LPL in tissues is regulated by angiopoietin-like proteins 3, 4, and 8 (ANGPTL). Dogma has held that these ANGPTLs inactivate LPL by converting LPL homodimers into monomers, rendering them highly susceptible to spontaneous unfolding and loss of enzymatic activity. Here, we show that binding of an LPL-specific monoclonal antibody (5D2) to the tryptophan-rich lipid-binding loop in the carboxyl terminus of LPL prevents homodimer formation and forces LPL into a monomeric state. Of note, 5D2-bound LPL monomers are as stable as LPL homodimers (i.e., they are not more prone to unfolding), but they remain highly susceptible to ANGPTL4-catalyzed unfolding and inactivation. Binding of GPIHBP1 to LPL alone or to 5D2-bound LPL counteracts ANGPTL4-mediated unfolding of LPL. In conclusion, ANGPTL4-mediated inactivation of LPL, accomplished by catalyzing the unfolding of LPL, does not require the conversion of LPL homodimers into monomers. Thus, our findings necessitate changes to long-standing dogma on mechanisms for LPL inactivation by ANGPTL proteins. At the same time, our findings align well with insights into LPL function from the recent crystal structure of the LPL•GPIHBP1 complex.

Indexed as

Amino Acid MotifsAngiopoietin-Like Protein 4AnimalsAntibodies, MonoclonalDimerizationHumansHypertriglyceridemiaLipoprotein LipaseProtein UnfoldingReceptors, LipoproteinTriglyceridesAngiopoietin-Like Protein 4ANGPTL4 protein, humanAntibodies, MonoclonalGPIHBP1 protein, humanLipoprotein LipaseReceptors, LipoproteinTriglyceridesGPIHBP1HDX-MSintravascular lipolysislipoprotein lipasesurface plasmon resonance

Identifiers

PMID32034094
PMCPMC7049152
OpenAlexW3004683289

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.